R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

Clinical trial NCT01133158 · COMPLETED

Trial details

NCT number: NCT01133158
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2009-07-01
Primary completion: 2013-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.